Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus

NCT: NCT07629557 · RECRUITING

NCT IDNCT07629557
StatusRECRUITING
Start Date2026-05-11
Completion2027-09
SponsorGlaukos Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

Clinical trial to evaluate the safety and feasibility of corneal cross-linking in both eyes on the same day in subjects with keratoconus.

Frequently Asked Questions

What is Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus?

Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus is a clinical trial registered under NCT07629557. Current status: RECRUITING.

What is the status of NCT07629557?

The current status of NCT07629557 (Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus) is: RECRUITING.

When did Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus start?

Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus started on 2026-05-11.

Related Devices

K212797iPrime Viscodelivery SystemGlaukos K220032iStent infinite Trabecular Micro-Bypass System, Model iS3Glaukos Corporation PMA P080030Intraocular pressure lowering implantGlaukos Corporation PMA P170043Intraocular pressure lowering implantGlaukos Corporation

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑